Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase II Study
International Journal of Radiation OncologyBiologyPhysics(2025)
Key words
bladder cancer,bladder preservation therapy (BPT),programmed cell death ligand 1 (PD-L1),atezolizumab,Radiation Therapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined